FLEX NATION

[mysticj]

RAMO news MMJ News out

http://ih.advfn.com/p.php?pid=nmona&article=63902865&symbol=RAMO

Las Vegas, NV - October 02, 2014 - InvestorsHub NewsWire - RAMOIL MANAGEMENT, Ltd (OTC Pink: RAMO) (PINKSHEETS: RAMO), would like to announce that it has begun research on the Charlottes Web or AC/DC cannabis strain, regarding cultivation and genetic engineering or manipulation.
RAMO Bio-Med, Inc. has acquired and planted sufficient seedlings of the strain AC/DC, a.k.a. Charlottes Web. Within 2 weeks, our scientist will begin to genetically engineer these clones and strain to increase the CBD % over 25% and reduce the THC % below 0.05% and ideally at or under 0.03% THC. Essentially, maximizing the CBD percentage and minimizing the THC percentage of this strain is our goal.

Finally, the RAMO Bio-Med in-house Scientists will increase the AC/DC or Charlottes Web clones' yield potential more than 20%, to maximize the plant production or yield (output).

Michael Goeree, Ramoil Management's Chairman, President and Chief Executive Officer, said, "It took some time to secure proper strains of AC/DC or Charlottes Web clones for research and genetic engineering. This will become the basis of our CBD based Medicine Production both here in America, as well as internationally."

Mr. Goeree further stated, "It is always a great day when the cornerstone of any structure is secured and set into place."

About Ramoil Management, Ltd.

Ramoil Management, Ltd. (RAMO) is a development stage company. The Company is an online wholesaler of E-cigarettes containing nutraceutical vapor oils, E-cigarette delivery systems and hydroponic lighting and nutrients.

About RAMO Bio-Med, Inc.

RAMO Bio-Med, Inc. is a wholly owned subsidiary of Ramoil Management, Ltd. (RAMO) and is a development stage company. The Company is the operating company of the newly acquired "Supercritical CO2 Molecular Extraction Technology" and will be building operating production facilities and research labs, both domestically and internationally, focused on its own proprietary strain of High CBD Extremely Low THC "Charlottes Webb" and Extraction Facilities (Labs and Manufacturing), for the development, production and sales of CBD extractions, concentrates and medicines.